What is Carolon?
Established in 1975, Carolon has solidified its reputation as a pioneer in the United States compression hosiery industry. The company specializes in a comprehensive suite of medical-grade solutions, including anti-embolism stockings, vascular hosiery, and advanced wound care systems. By integrating multi-layer compression technology with a focus on patient comfort, Carolon serves as a critical partner for clinicians seeking effective vascular management tools. As a family-owned enterprise, the firm balances traditional manufacturing excellence with modern logistics, providing nationwide distribution that ensures high-quality medical devices remain accessible to those requiring long-term vascular support.
How much funding has Carolon raised?
Carolon has raised a total of $1.3M across 2 funding rounds:
Debt
$350K
Debt
$929K
Debt (2020): $350K with participation from PPP
Debt (2021): $929K led by PPP
Key Investors in Carolon
PPP
Public-Private Partnership
What's next for Carolon?
With the recent influx of capital, Carolon is positioned to accelerate its strategic initiatives, likely focusing on the modernization of its manufacturing infrastructure and the expansion of its wound care portfolio. The company's transition into a more robust enterprise-level operational model suggests a focus on increasing market share within the competitive medical device landscape. By leveraging this financing, Carolon aims to enhance its supply chain resilience and potentially explore new technological integrations within its compression systems, ensuring that it remains at the forefront of vascular health innovation while maintaining the high standards of quality that have defined its nearly five-decade history.
See full Carolon company page
